International Union Against Tuberculosis and Lung Disease
Basic occupational safety and health for respiratory diseases: A desk guide for health facilities
Publication
09 Sep 2024
The use of non-steroidal anti-inflammatory drugs (NSAIDs) in patients with COVID-19
01 May 2020
Concerns have been raised that NSAIDs may be associated with an increased risk of adverse effects when used in patients with acute viral respiratory infections, including COVID-19.1,2 This review aimed to assess the effects of prior and current use of NSAIDs in patients with acute viral respiratory infections on acute severe adverse events (including mortality, the acute respiratory distress syndrome (ARDS), acute organ failure, and opportunistic infections), on acute health care utilization (including hospitalization, intensive care unit (ICU) admission, supplemental oxygen therapy, and mechanical ventilation) as well as on quality of life and long-term survival.
